A new pharmacological approach to gastrointestinal cancer at high risk of relapse based on maintenance of the cytostatic effect (Articolo in rivista)

Type

• Articolo in rivista (Classe)
• Prodotto della ricerca (Classe)

Label

• A new pharmacological approach to gastrointestinal cancer at high risk of relapse based on maintenance of the cytostatic effect (Articolo in rivista) (literal)

Anno

• 2010-01-01T00:00:00+01:00 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi

• 10.1007/s13277-010-0065-1 (literal)

Alternative label

• Nicolini, Andrea; Conte, Massimo; Rossi, Giuseppe; Ferrari, Paola; Carpi, Angelo; Miccoli, Paolo (2010)
  A new pharmacological approach to gastrointestinal cancer at high risk of relapse based on maintenance of the cytostatic effect
  in Tumor biology
  (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

• Nicolini, Andrea; Conte, Massimo; Rossi, Giuseppe; Ferrari, Paola; Carpi, Angelo; Miccoli, Paolo (literal)

Pagina inizio

• 523 (literal)

Pagina fine

• 532 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

• 31 (literal)

Rivista

• Tumor biology (Rivista)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali

• 10 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo

• 5 (literal)

Note

• ISI Web of Science (WOS) (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

• Department of Internal Medicine, University of Pisa, Department of Surgery, University of Pisa, Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, CNR, Pisa, Department of Reproduction and Ageing, University of Pisa, (literal)

Titolo

• A new pharmacological approach to gastrointestinal cancer at high risk of relapse based on maintenance of the cytostatic effect (literal)

Abstract

• In metastatic colorectal and other locally advanced gastrointestinal cancers, the mechanisms of tumor growth and/or immune escape by residual cancer cells after curative resection often provoke tumor recurrence. Current adjuvant therapy is based on pharmacological administration up to 6-8 months after surgery. We hypothesized that the long-term, cytostatic action from repeated post-adjuvant administration of 5-fluorouracil (FU)-leucovorin (LV) cycles, as a result of the downregulation of the above-mentioned cellular mechanisms, could halt tumor progression. An active prospective cohort, including 19 patients (study group) at high risk of relapse, was considered. All patients received repeated post-adjuvant administration of 5-FU-LV cycles for up to 52-60 months following curative surgery (total cumulative dose of about 90 g and mean follow-up of 70.6 +/- A 49.7 months). The 5-year disease-free interval (DFS) and overall survival (OS) were 80.4 +/- A 10.2% and 87.1 +/- A 8.6%, respectively, which is very different from the recent literature that has reported 5-year DFS and OS values of 31.8% and 40.1%, respectively. These findings suggest that this new pharmacological approach based on the long-term maintenance of a cytostatic effect with 5-FU-LV can produce a relevant improvement in the outcome of this population. (literal)

Prodotto di

• Istituto di fisiologia clinica (IFC) (Istituto)

Autore CNR

• GIUSEPPE ROSSI (Unità di personale interno)

Insieme di parole chiave

• Parole chiave di "A new pharmacological approach to gastrointestinal cancer at high risk of relapse based on maintenance of the cytostatic effect" (Insieme di parole chiave)

Incoming links:

Autore CNR di

• GIUSEPPE ROSSI (Unità di personale interno)

Prodotto

• Istituto di fisiologia clinica (IFC) (Istituto)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• Tumor biology (Rivista)

Insieme di parole chiave di

• Parole chiave di "A new pharmacological approach to gastrointestinal cancer at high risk of relapse based on maintenance of the cytostatic effect" (Insieme di parole chiave)